After being given roughly a month to show that it had gotten its financials in order, Osiris Therapeutics (NASDAQ: OSIR) has failed and faces a real chance of being delisted. On Monday, the company provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ. In March, Osiris received a Continue reading →
Making 45% Annually Trading Options Against Dividend Growth Stocks
WHAT WE DO? WE SELL OPTIONS FOR INCOME. WE USE THAT INCOME TO BUY DIVIDEND GROWTH STOCKS!
CHECK OUR TRADES ON OUR MeWe PAGE!
Posts Tagged With 'Osiris Therapeutics'
Medical Device Companies are Thriving, But Steer Clear of This One
Many medical device companies are considered solid investments because they are in a space that has a broad reach. This is especially the case for those companies that offer advanced products. Such is the case for Osiris Therapeutics (NASDAQ: OSIR). However, the regenerative medicine products that it develops, manufactures, markets and distributes may be stalled Continue reading →
Recent Comments